Fresenius Medical Care AG
FMS
View Detailed Chart
24.080USD
-0.250-1.03%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
6.98BMarket Cap
17.71P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.03%
5 Days
+6.08%
1 Month
+1.73%
6 Months
+2.38%
Year to Date
+1.09%
1 Year
-0.91%
View Detailed Chart
TradingKey Stock Score of Fresenius Medical Care AG
Currency: USD Updated: 2026-02-06Key Insights
Fresenius Medical Care AG's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 31 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 27.38.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Fresenius Medical Care AG's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Fresenius Medical Care AG Highlights
StrengthsRisks
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 78.64%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 78.64%.
Undervalued
The company’s latest PE is 17.71, at a low 3-year percentile range.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 155.10K shares of this stock.
Analyst Rating
Based on
7
analysts
Hold
Current Rating
27.383
Target Price
+12.46%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Fresenius Medical Care AG News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Fresenius Medical Care AG Info
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Ticker SymbolFMS
CompanyFresenius Medical Care AG
CEOCordola (Craig)
Websitehttps://www.freseniusmedicalcare.com/
Related Instruments
+2.98%
+0.07%
+1.60%
+2.48%
+0.31%
-1.14%
-0.05%
-2.35%
-1.78%
+2.65%
+2.59%
+2.03%
+2.01%
+2.38%
+1.74%
+0.16%
+0.78%
+1.72%
+0.59%
-2.02%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
68615.990
-1354.140 (-1.93%)
282.580
+22.390 (+8.61%)
2017.910
-33.820 (-1.65%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
